acetylcysteine has been researched along with iopamidol in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 11 (64.71) | 29.6817 |
| 2010's | 6 (35.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Cheng, JJ; Kuan, P; Shyu, KG | 1 |
| Chan, TM; Chow, WH; Fan, K; Kay, J; Kwok, OH; Lam, WF; Lee, CH; Lo, SK; Yip, A | 1 |
| Eckel, F; Fritsch, R; Hamar, P; Heemann, U; Hennico, R; Hennig, M; Huber, W; Meining, A; Rosenbrock, H; Saur, D; Schenk, C; Schmelz, R; Schmid, RM; Sennefelder, A; Wacker, A; Weiss, W | 1 |
| Alscher, DM; Brenner, S; Butscheid, M; Kimmel, M; Klotz, U; Kuhlmann, U | 1 |
| Locatelli, F | 1 |
| Aublet-Cuvelier, B; Cellarier, E; Decalf, V; Deteix, P; Heng, AE; Marcaggi, X; Motreff, P; Souweine, B | 1 |
| Bell, SP; Chen, Z; Dauerman, HL; LeWinter, MM; Meyer, M; Selby, DE; Singla, DK | 1 |
| Fischell, TA | 1 |
| Coppola, JT; Doucet, S; Katholi, RE; Mody, KR; Sharma, SK; Solomon, R; Staniloae, CS | 1 |
| Ahmad, A; Aloisi, C; Catania, MA; Cuzzocrea, S; Di Paola, R; Esposito, E; Italiano, D; Mazzon, E; Mondello, P; Mondello, S | 1 |
| Inci, MF; Inci, R; Salk, I; Solak, O; Vurdem, UE | 1 |
| Aloisi, C; Arena, A; Baldari, S; Buemi, F; Buemi, M; Giardina, C; Lacquaniti, A; Lupica, R; Murè, G; Visalli, C | 1 |
| Bell, SP; Chen, Z; Christian, TF; Dauerman, HL; Gibson, PC; Keating, FF; Lachapelle, RR; LeWinter, MM; Meyer, M; Nyotowidjojo, I | 1 |
6 trial(s) available for acetylcysteine and iopamidol
| Article | Year |
|---|---|
Acetylcysteine protects against acute renal damage in patients with abnormal renal function undergoing a coronary procedure.
Topics: Acetylcysteine; Aged; Comorbidity; Contrast Media; Coronary Angiography; Coronary Disease; Creatinine; Female; Free Radical Scavengers; Humans; Iopamidol; Kidney; Kidney Failure, Chronic; Male; Middle Aged; Prospective Studies | 2002 |
Acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and intervention: a randomized controlled trial.
Topics: Acetylcysteine; Adult; Aged; Aged, 80 and over; Antioxidants; Contrast Media; Coronary Angiography; Creatinine; Double-Blind Method; Female; Free Radical Scavengers; Humans; Iopamidol; Kidney; Kidney Function Tests; Male; Middle Aged; Prospective Studies; Renal Insufficiency | 2003 |
Prophylaxis of contrast material-induced nephropathy in patients in intensive care: acetylcysteine, theophylline, or both? A randomized study.
Topics: Acetylcysteine; Adult; Aged; Aged, 80 and over; Blood Urea Nitrogen; Contrast Media; Creatinine; Critical Care; Drug Combinations; Female; Follow-Up Studies; Free Radical Scavengers; Humans; Iopamidol; Kidney Diseases; Male; Middle Aged; Phosphodiesterase Inhibitors; Prospective Studies; Protective Agents; Risk Factors; Theophylline; Time Factors | 2006 |
Improved estimation of glomerular filtration rate by serum cystatin C in preventing contrast induced nephropathy by N-acetylcysteine or zinc--preliminary results.
Topics: Acetylcysteine; Administration, Oral; Aged; Contrast Media; Coronary Angiography; Coronary Disease; Creatinine; Cystatin C; Cystatins; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Free Radical Scavengers; Glomerular Filtration Rate; Humans; Injections, Intravenous; Iopamidol; Male; Protease Inhibitors; Renal Insufficiency; Retrospective Studies; Severity of Illness Index; Treatment Outcome; Zinc Compounds | 2008 |
Is treatment with N-acetylcysteine to prevent contrast-induced nephropathy when using bicarbonate hydration out of date?
Topics: Acetylcysteine; Aged; Contrast Media; Coronary Angiography; Coronary Disease; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Free Radical Scavengers; Glomerular Filtration Rate; Humans; Injections, Intravenous; Iopamidol; Kidney Diseases; Male; Prospective Studies; Sodium Bicarbonate; Treatment Outcome; Triiodobenzoic Acids | 2008 |
Can neutrophil gelatinase-associated lipocalin help depict early contrast material-induced nephropathy?
Topics: Acetylcysteine; Adult; Aged; Aged, 80 and over; Chi-Square Distribution; Contrast Media; Creatinine; Diagnostic Imaging; Enzyme-Linked Immunosorbent Assay; Female; Gelatinases; Glomerular Filtration Rate; Humans; Iopamidol; Kidney Diseases; Lipocalins; Male; Meglumine; Middle Aged; Organometallic Compounds; Proportional Hazards Models; Prospective Studies; Radiopharmaceuticals; Risk Factors; ROC Curve; Sensitivity and Specificity; Sodium Bicarbonate; Sodium Chloride | 2013 |
11 other study(ies) available for acetylcysteine and iopamidol
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Letter regarding article by Solomon et al, "Cardiac Angiography in REnally Impaired Patients (CARE) study: a randomized double-blind trial of contrast-induced nephropathy in patients with chronic kidney disease".
Topics: Acetylcysteine; Confounding Factors, Epidemiologic; Contrast Media; Coronary Angiography; Creatinine; Double-Blind Method; Humans; Iopamidol; Kidney Diseases; Randomized Controlled Trials as Topic; Research Design; Sampling Studies; Sodium Bicarbonate; Triiodobenzoic Acids | 2008 |
N-acetylcysteine-enhanced contrast provides cardiorenal protection.
Topics: Acetylcysteine; Angioplasty, Balloon, Coronary; Animals; Apoptosis; Contrast Media; Creatinine; Disease Models, Animal; Feasibility Studies; Free Radical Scavengers; Iopamidol; Kidney; Kidney Diseases; Myocardial Infarction; Myocardium; Risk Factors; Swine | 2009 |
Contrast loaded with N-acetylcysteine for coronary imaging during percutaneous coronary intervention: a new concept for renal and myocardial protection during percutaneous coronary intervention.
Topics: Acetylcysteine; Angioplasty, Balloon, Coronary; Animals; Apoptosis; Contrast Media; Disease Models, Animal; Free Radical Scavengers; Iopamidol; Kidney; Kidney Diseases; Myocardial Infarction; Myocardium | 2009 |
N-Acetylcysteine added to volume expansion with sodium bicarbonate does not further prevent contrast-induced nephropathy: results from the cardiac angiography in renally impaired patients study.
Topics: Acetylcysteine; Aged; Buffers; Coronary Angiography; Creatinine; Female; Free Radical Scavengers; Glomerular Filtration Rate; Humans; Iopamidol; Kidney Diseases; Male; Plasma Substitutes; Retrospective Studies; Risk Factors; Sodium Bicarbonate; Triiodobenzoic Acids | 2009 |
Protective effect of apocynin, a NADPH-oxidase inhibitor, against contrast-induced nephropathy in the diabetic rats: a comparison with n-acetylcysteine.
Topics: Acetophenones; Acetylcysteine; Acute-Phase Proteins; Animals; Apoptosis; Contrast Media; Cytosine; Diabetic Nephropathies; Enzyme Activation; Enzyme Inhibitors; Glutathione Transferase; Iopamidol; Isoenzymes; Kidney Glomerulus; Lipocalin-2; Lipocalins; Male; NADPH Oxidases; Poly(ADP-ribose) Polymerases; Potassium; Proto-Oncogene Proteins; Rats; Rats, Wistar; Sodium; Time Factors; Tyrosine | 2012 |
[ Use of N-acetylcysteine for the prevention of contrast-induced nephropathy in rats].
Topics: Acetylcysteine; Animals; Antioxidants; Arterioles; Contrast Media; Drug Evaluation, Preclinical; Iopamidol; Kidney; Kidney Diseases; Kidney Glomerulus; Male; Nephritis, Interstitial; Random Allocation; Rats; Rats, Wistar; Single-Blind Method; Water Deprivation | 2012 |
High dose intracoronary N-acetylcysteine in a porcine model of ST-elevation myocardial infarction.
Topics: Acetylcysteine; Animals; Contrast Media; Coronary Angiography; Disease Models, Animal; Female; Free Radical Scavengers; Iopamidol; Myocardial Infarction; Myocardial Reperfusion Injury; Swine | 2013 |